Bryan Fellman
Senior Biostatistician
Positions
- Senior Biostatistician
-
Pediatrics - Epidemiology
Baylor College of Medicine
Education
- MS from Texas A&M University
- College Station, Texas
- Statistics
- BS from Texas A&M University
- College Station, Texas
- Applied Mathematics
Professional Interests
- Bayesian adaptive clinical trial designs
- Phase I/II clinical trials
- Survival analysis
- Oncology
Websites
Selected Publications
-
Ludmir EB, Sherry AD, Fellman BM, Liu S, Tang C.. " Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial " J Clin Oncol. 2024 Nov 10; 42(32):3795-3805
Pubmed PMID: 39102622. -
Brodsky AL, Asare A, Fellman B, Anderson K, Yao J, Lee S, Tran H, Xu X, Liu J, Celestino J, Hajek RA, Morgan MB, Mohammad M, Soliman, Coleman RL, Westin SN. " Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights " 2026 Apr 1; 2(7):1234-1245
Pubmed PMID: 41528970. -
ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer " Int J Gynecol Cancer. 2021 Oct 31; (10):1317-1325
Pubmed PMID: 34493587. -
Katherine C Kurnit, Grace N Kim, Bryan M Fellman, Diana L Urbauer, Gordon B Mills, Wei Zhang, Russell R Broaddus. " CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence " Modern Pathology. 2017 Jul 1;
Pubmed PMID: 28281553.
Log In to edit your profile